Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

Abstract Background Plasma amyloid-β (Aβ) levels are increasingly studied as a potential accessible marker of cognitive impairment and dementia. However, it remains underexplored whether plasma Aβ levels including the novel Aβ peptide 1–38 (Aβ1–38) relate to preclinical markers of neurodegeneration...

Full description

Bibliographic Details
Main Authors: Saima Hilal, Frank J. Wolters, Marcel M. Verbeek, Hugo Vanderstichele, M. Kamran Ikram, Erik Stoops, M. Arfan Ikram, Meike W. Vernooij
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Alzheimer’s Research & Therapy
Subjects:
Plasma amyloid-β levels
Magnetic resonance imaging
Atrophy
Dementia
Population-based
Online Access:http://link.springer.com/article/10.1186/s13195-018-0395-6

Internet

http://link.springer.com/article/10.1186/s13195-018-0395-6

Similar Items